NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
(85% Positive) NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Provides Update on trial for recurrent IDH1 mutant high-grade glioma
(85% Positive) NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Provides Update on trial for recurrent IDH1 mutant high-grade glioma
📋 NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) - Clinical Trial Update
Filing Date: 2026-08-13
Accepted: 2026-08-13 17:21:36
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: